Cargando…

Selected Derivatives of Erythromycin B-In Silico and Anti-Malarial Studies

Erythromycin A is an established anti-bacterial agent against Gram-positive bacteria, but it is unstable to acid. This led to an evaluation of erythromycin B and its derivatives because these have improved acid stability. These compounds were investigated for their anti-malarial activities, by their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhadra, Pranab K., Magwaza, Rachael N., Nirmalan, Niroshini, Freeman, Sally, Barber, Jill, Arsic, Biljana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618316/ https://www.ncbi.nlm.nih.gov/pubmed/34832380 http://dx.doi.org/10.3390/ma14226980

Ejemplares similares

Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
por: Matthews, Holly, et al.
Publicado: (2013)

Evaluation of 4-Aminoquinoline Hydrazone Analogues as Potential Leads for Drug-Resistant Malaria
por: Magwaza, Rachael N., et al.
Publicado: (2023)

Development of pH sensitive polymeric nanoparticles of erythromycin stearate
por: Bhadra, Sulekha, et al.
Publicado: (2016)

“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
por: Matthews, Holly, et al.
Publicado: (2016)

In silico and in vivo anti-malarial investigation on 1-(heteroaryl)-2-((5-nitroheteroaryl)methylene) hydrazine derivatives
por: Tahghighi, Azar, et al.
Publicado: (2020)

Exploring anti-malarial potential of FDA approved drugs: an in silico approach
por: Ramakrishnan, Gayatri, et al.
Publicado: (2017)

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
por: Navarro, Maribel, et al.
Publicado: (2014)

In silico analysis for factors affecting anti-malarial penetration into red blood cells
por: Pornputtapong, Natapol, et al.
Publicado: (2020)

Novel pantothenate derivatives for anti-malarial chemotherapy
por: Pett, Helmi E, et al.
Publicado: (2015)

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
por: Chen, Yizhe, et al.
Publicado: (2021)

In Silico Investigation of Selected Pesticides and Their Determination in Agricultural Products Using QuEChERS Methodology and HPLC-DAD
por: Petrović, Stefan, et al.
Publicado: (2023)

Measuring windows of selection for anti-malarial drug treatments
por: Kay, Katherine, et al.
Publicado: (2015)

Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
por: Tam, Dao Ngoc Hien, et al.
Publicado: (2020)

Influence of trace erythromycin and erythromycin-H(2)O on carbon and nutrients removal and on resistance selection in sequencing batch reactors (SBRs)
por: Fan, Caian, et al.
Publicado: (2009)

Erythromycin Induced Nightmares
por: Møller, Maria E, et al.
Publicado: (2016)

Computational Studies on Selected Macrolides Active against Escherichia coli Combined with the NMR Study of Tylosin A in Deuterated Chloroform
por: Arsic, Biljana, et al.
Publicado: (2022)

Inhibition of Erythromycin and Erythromycin-Induced Resistance among Staphylococcus aureus Clinical Isolates
por: Mahfouz, Aya A., et al.
Publicado: (2023)

Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations
por: Matthews, Holly, et al.
Publicado: (2017)

In Silico and In Vivo Anti-Malarial Studies of 18β Glycyrrhetinic Acid from Glycyrrhiza glabra
por: Kalani, Komal, et al.
Publicado: (2013)

The potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling
por: Onguéné, Pascal Amoa, et al.
Publicado: (2014)

Erythromycin for prokinesis: imprudent prescribing?
por: Dall'Antonia, Martino, et al.
Publicado: (2006)

Akathisia with Erythromycin: Induced or precipitated?
por: Sachdeva, Ankur, et al.
Publicado: (2015)

Erythromycin Seromadesis in Orthopedic Surgery
por: Salgado, Martin, et al.
Publicado: (2016)

Improved negative selection protocol for Plasmodium berghei in the rodent malarial model
por: Orr, Rachael Y, et al.
Publicado: (2012)

Anti-Malarial Measures in Travancore
por: Watson, Malcolm
Publicado: (1932)

The Future of Anti-Malarial Research
por: Senior-White, Ronald, et al.
Publicado: (1927)

Anti-Malarial Sanitation in India
Publicado: (1904)

Anti-Malarial Sanitation in India
por: Goodbody, C. M.
Publicado: (1904)

Punjab Anti-Malarial Campaign
Publicado: (1911)

Anti-Malarial Operations in India
por: Bose, P. N.
Publicado: (1941)

The Synthetic Anti-Malarial Compounds
Publicado: (1933)

Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii
por: Mout, Rubul, et al.
Publicado: (2012)

Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria
por: Yeo, Seon-Ju, et al.
Publicado: (2017)

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases
por: Cheong, Dorothy H.J., et al.
Publicado: (2020)

Postantibiotic effects and postantibiotic sub-MIC effects of tilmicosin, erythromycin and tiamulin on erythromycin-resistant Streptococcus suis
por: Wang, Liping, et al.
Publicado: (2009)

Effect of erythromycin and rifampicin on monoethylglycinexylidide test
por: Bhise, Satish Balkrishna, et al.
Publicado: (2008)

Erythromycin resistance in Streptococcus pyogenes in Italy.
por: Bassetti, M, et al.
Publicado: (2000)

Streptococcus pyogenes erythromycin resistance in Italy.
por: Bassetti, M, et al.
Publicado: (1999)

Erythromycin: an alternative for the management of oral mucositis?
por: Teixeira, Dieni Silveira, et al.
Publicado: (2022)

Development of Novel Erythromycin Derivatives with Inhibitory Activity against Proliferation of Tumor Cells
por: Wu, Lan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bc6v1jt5ub746106gc33obh6v1